These molecular tests are good for screening those who are or have been infected; they cannot determine if the infection is active, i.e., whether someone testing positive can infect others. Those screened will have to wait for additional tests (all with much longer time to results than the N-Assay) or for a long enough period of time (at least 2 weeks?) to see if symptoms develop. During these waiting periods, they have to be put under quarantine.

The N-Assay will determine if the infection is active. It would be most useful to determine who in the screened population can go home or stay in quarantine leading to the most efficient use of limited resources. There is a high degree of utility in such a diagnostic tool -- forget $1 royalty. How much would you pay if your choices are to be in quarantine for 2 weeks (all the while worrying about who else you might've infected) or to know definitively in under an hour?